Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and... Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies. Show more
INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Oct. 2, 2024 PLYMOUTH MEETING, Pa., Oct. 2, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...
INOVIO to Present at Upcoming Scientific Conferences PR Newswire PLYMOUTH MEETING, Pa., Oct. 1, 2024 PLYMOUTH MEETING, Pa., Oct. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...
INOVIO to Present at Upcoming Scientific Conference PR Newswire PLYMOUTH MEETING, Pa., Sept. 17, 2024 PLYMOUTH MEETING, Pa., Sept. 17, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...
INOVIO Reports Second Quarter 2024 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH MEETING, Pa., Aug. 8, 2024 PLYMOUTH MEETING, Pa., Aug. 8, 2024 /PRNewswire/ -- INOVIO...
INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Aug. 1, 2024 PLYMOUTH MEETING, Pa., Aug. 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology...
Inovio Receives Advanced Therapy Medicinal Product Certificate from European Medicines Agency for Quality and Non-Clinical Data for Lead Candidate INO-3107 PR Newswire PLYMOUTH MEETING, Pa., July...
INOVIO to Report Second Quarter 2024 Financial Results on August 8, 2024 PR Newswire PLYMOUTH MEETING, Pa., July 25, 2024 PLYMOUTH MEETING, Pa., July 25, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire PLYMOUTH MEETING, Pa., July 11, 2024 Award recognizes the...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.2181 | 4.06001600923 | 5.3719 | 5.79 | 5.35 | 431302 | 5.62469035 | CS |
| 4 | -1.31 | -18.9855072464 | 6.9 | 6.9999 | 5.3 | 379238 | 5.80124226 | CS |
| 12 | -4.97 | -47.0643939394 | 10.56 | 12.33 | 5.3 | 308419 | 7.2910645 | CS |
| 26 | -5.41 | -49.1818181818 | 11 | 13.44 | 5.3 | 344589 | 8.85970475 | CS |
| 52 | -0.53 | -8.66013071895 | 6.12 | 14.748 | 3.888 | 1283838 | 7.27102911 | CS |
| 156 | -80.93 | -93.5390661119 | 86.52 | 93.24 | 3.888 | 4177025 | 23.3750468 | CS |
| 260 | -19.85 | -78.0267295597 | 25.44 | 426 | 3.888 | 9051959 | 122.73376256 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
